Benign hepatic tumors and oral contraceptive pills

      This paper is only available as a PDF. To read, Please Download here.


      In order to consider possible environmental factors related to the development of benign hepatic tumors, all reports of this disorder in the case records of five different hospitals in Rochester, New York, during the past 10 years were reviewed. Seven patients with benign hepatic tumors of the liver and two with peliosis hepatis were identified. Among the seven with a benign hepatic tumor, four were women currently receiving oral contraceptives; one had been receiving this medication in the past, and two had no history of exposure to any steroid whatsoever. The two patients with peliosis hepatis were receiving long-term androgenic anabolic steroids. Dilated, thin-walled vessels and vascular spaces were a more prominent feature of the tumor seen in four patients receiving oral contraceptive pills. It is emphasized in this report that benign hepatic tumors do occur in men and in patients with cirrhotic liver without the use of any kind of steroids.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Warvi N
        Primary neoplasms of the liver.
        Arch Pathol. 1944; 37: 367
        • Henson Jr, SW
        • Gray HK
        • Dockerty MD
        Benign tumors of the liver.
        Surg Gynecol Obstet. 1956; 103: 23
        • Baum JK
        • Bookstein JJ
        • Holtz F
        • et al.
        Possible association between benign hepatomas and oral contraceptives.
        Lancet. 1973; 2: 926
        • O'Sullivan JP
        • Wilding RP
        Liver hamartomas in patients on oral contraceptives.
        Br Med J. 1974; 3: 7
        • Cahal DA
        Assessment of safety of drugs.
        Br Med J. 1966; 1: 854
        • Contostavlos DL
        Benign hepatomas and oral contraceptives (Letter).
        Lancet. 1973; 2: 1200
        • Knapp WA
        • Ruebner BH
        Hepatomas and oral contraceptives.
        Lancet. 1974; 1: 270
        • Kelso DR
        Benign hepatomas and oral contraceptives (Letter).
        Lancet. 1974; 1: 315
        • Horvath E
        • Kovacs K
        • Ross RC
        Benign hepatoma in young women on contraceptive steroids (Letter).
        Lancet. 1974; 1: 357
        • Antoniades K
        • Brooks CE
        Hemoperitoneum from liver cell adenoma in a patient on oral contraceptives.
        Surgery. 1975; 77: 137
        • Minow RA
        • Tompkins RK
        • Gritnick GL
        Diarrhea syndrome in hepatic adenoma.
        Am J Digest Dis. 1975; 20: 182
        • Mays ET
        • Christopherson WM
        • Barrows GH
        Focal nodular hyperplasia of the liver. Possible relationship to oral contraceptives.
        Am J Clin Pathol. 1974; 61: 735
        • Stauffer JQ
        • Lapinski MW
        • Hanold DJ
        • et al.
        Focal nodular hyperplasia of the liver and intrahepatic hemorrhage in young women on oral contraceptives.
        Ann Intern Med. 1975; 83: 301
        • Berg JW
        • Ketelaar RJ
        • Rose EF
        • et al.
        Hepatomas and oral contraceptives (Letter).
        Lancet. 1974; 2: 349
        • Edmondson HA
        Tumors of the liver and intrahepatic bile ducts. Atlas of Tumor Pathology.
        in: Armed Forces Institute of Pathology, Washington, D.C1958: 193 (fasc 25)
      1. International classification of diseases, adapted.
        Public Health Service publication no. 1963. Dec. 1968; (8th Rev.)
      2. Standard Nomenclature of Diseases and Operations, issued by AMA.
        5th ed. McGraw-Hill, New York1961
        • Bagheri SA
        • Boyer JL
        Peliosis hepatis associated with androgenic anabolic steroid therapy. A severe form of hepatic injury.
        Ann Intern Med. 1974; 81: 610
        • Ross D
        • Jorga P
        • Medo M
        • et al.
        Regression of focal nodular hyperplasia after discontinuation of oral contraceptives.
        Ann Intern Med. 1976; 85: 203
        • Committee on Safety of Medicines
        carcinogenicity tests of oral contraceptives.
        Her Majesty's Stationery Office, London1972
        • Perez V
        • Gorosdisch S
        • De Martive J
        • et al.
        Oral contraceptives: long term use produces fine structural changes in liver mitochondria.
        Science. 1969; 165: 805
        • Udenfriend S
        Arene oxide intermediates in enzymatic hydroxylation and their significance with respect to drug toxicity.
        Ann NY Acad Sci. 1971; 179: 295
        • Lingeman CH
        Liver-cell neoplasms and oral contraceptives.
        Lancet. 1974; 1: 64
        • Black NM
        • Leish Jr, P
        Mammary carcinogenesis.
        NY State J Med. 1972; 72: 1601
        • Herbst AI
        • Kurman RJ
        • Scully RE
        Vaginal and surgical abnormalities after exposure to stilbestrol in utero.
        Obstet Gynecol. 1972; 40: 287
        • Edmondson HA
        • Henderson B
        • Benton B
        Liver-cell adenomas associated with use of oral contraceptives.
        N Engl J Med. 1976; 296: 470